# The EXCEL – First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

- Link: https://www.thailand-business-news.com/pr-news/the-excel-first-of-its-kind-study-highlights-critical-role-of-essential-phospholipids-in-improving-fatty-liver-disease
- Published: 2026-04-27T22:18:00+07:00
- Author: PR Newswire

PARIS, April 27, 2026 /PRNewswire/ — A new study has established that treatment 
with essential phospholipids (Essentiale) resulted in a 2.5 times greater reduction
in liver fat, significant improvement in fatigue and improvement of glycaemic control
in individuals with Metabolic dysfunction–Associated Steatotic Liver Disease (MASLD)–
also known as ‘Fatty Liver Disease’ – than diet and exercise alone.

The results were found by the EXCEL clinical trial from Essentiale (an Opella brand)–
a multi-centre, randomized, double-blind, placebo-controlled study and the first
of its kind to test essential phospholipids (EPLs). The study examined MASLD patients
with comorbidities such as type 2 diabetes, hyperlipidaemia, or obesity.

MASLD is the most prevalent chronic liver disease worldwide, affecting an estimated
30% of the adult population, with projections indicating over 55% of adults worldwide
will be affected by 2040^([1]). 

Often considered a "silent" condition, fatty liver disease is frequently associated
with a debilitating constellation of symptoms such as abdominal pain, fatigue, sleep
issues, bloating, depressive symptoms, anxiety and metabolic risks.

**Professor Norbert Stefan, Holder of the Chair of Clinical and Experimental Diabetology
at the University of Tübingen."This groundbreaking research marks an important moment
for the millions of people currently living with MASLD. The EXCEL study underscores
the clinical importance of early intervention and bridges the gap between scientific
evidence and patient experience. By demonstrating measurable improvements in liver
fat reduction and improvement of fatigue, this study reinforces the vital message
that effective, evidence-based options exist to transform outcomes and restore hope
for a more energized life in people with MASLD."

The EXCEL study used modern, non-invasive imaging to measure liver fat alongside
a validated, disease-specific questionnaire to assess the treatment’s impact on 
patient wellbeing. The main trial results showed that, when used in addition to 
diet and exercise, essential phospholipids were associated with:

 ◦ A 2.5 times greater reduction in liver fat compared with lifestyle intervention
   alone, as measured by FibroScan CAP (Controlled Attenuation Parameter).
 ◦ A statistically significant improvement in patient-reported fatigue, a primary
   and often overlooked symptom of MASLD. This outcome was formally assessed using
   the validated CLDQ-MASLD score, a standardized measure of well-being in individuals
   with chronic liver disease.
 ◦ The study also noted that treatment with EPLs significantly reduced HbA1c levels,
   a key marker for glycemic control in patients with type 2 diabetes, making the
   findings particularly relevant for the large percentage of MASLD patients with
   co-existing metabolic conditions.

**Nikunj Thakker Global Brand General Manager Essentiale, Opella."The EXCEL study
proves that timing is everything. When caught early, a significant portion of MASLD
cases can be reversible. This evidence-based treatment, using essential phospholipids
combined with diet and exercise, actively reduces liver fat and tackles debilitating
fatigue head-on, changing outcomes for the billions globally living with Fatty Liver
Disease."

The full study methodology and findings were published in **Liver International**:

[https://onlinelibrary.wiley.com/doi/10.1111/liv.70601](https://onlinelibrary.wiley.com/doi/10.1111/liv.70601).

^([1])  Bellentani S., Scaglioni F., Marino M., and Bedogni G., "Epidemiology of
Non–Alcoholic Fatty Liver Disease," Digestive Diseases 28, no. 1 (2010): 155–161.

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [The EXCEL – First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease ](http://www.prnasia.com/story/archive/4943189_AE43189_0?rand=184833)